Published on
September 1, 2026
- 11:00 GMT
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®
Creates a catalyst for growth through a larger GI business, with a significantly stronger liquidity position and provides additional expansion opportunities RedHill Biopharma (NASDAQ:RDHL) RALEIGH, NC, UNITED STATES, September 1, 2026 /EINPresswire.com …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
